Rebel Category: REBEL EM

The COVID-OUT Trial: Does Metformin Reduce the Risk of Long COVID?

Background: The COVID-19 pandemic has been the focus of massive research efforts over the last three years. Our understanding of the disease and effective treatments to reduce mortality have progressed rapidly during this time. However, the medical community is only …

Read More
Infectious Disease

Rethinking the Role of TXA: Are We Asking Too Much?

Background: Injuries are a major cause of death worldwide. Hemorrhage accounts for about 1/3 of all trauma deaths and as such, it should be our goal to find treatments to decrease death from hemorrhage. Our bodies have a finely tuned …

Read More

Rosh Review EM Scholar Monthly Question

A 45-year-old man is brought in by EMS after being found unconscious by his partner. He is confused and agitated. His vital signs are a BP of 90/60 mm Hg, HR of 120 bpm, RR of 24/min, and T of …

Read More

The Safety and Efficacy of Push Dose Vasopressors in Critically Ill Adults

Background Information: Acute Hypotension is associated with increased morbidity and mortality. Continuous vasopressor infusions have previously been the mainstay of treatment. However, peripherally dosed push dose pressors, (PDPs), are beginning to be administered more frequently for management of acute hypotension.1-4 …

Read More

Trauma Resuscitation Updates

I recently gave a talk on the initial management of trauma patients with hemorrhagic shock.  In the initial management of trauma resuscitation there are 4 key principles that should be followed: Control bleeding Restore tissue perfusion Minimize iatrogenic injury from …

Read More